TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TRVI

Trevi Therapeutics Inc

Healthcare · Biotechnology

14.70$ +1.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement TRVI
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – –
– -100.0% – +69.6% +20.5% +6.4% -14.0% +186.0% +19.5% -10.2%
– – – – – – – – – –
– -11.8% +130.9% +37.4% +15.5% +2.9% -13.7% +19.4% +66.3% -15.0%
– +29.2% +102.4% +68.5% +39.1% -6.6% +6.1% +1.7% +18.6% +30.5%
– -4.5% +123.5% +44.7% +21.9% 0.0% -7.9% +13.4% +51.9% -4.3%
– – – – – – – – – –
– – -94.8% +254.0% -26.0% +163.6% -35.1% -49.9% -99.0% -100.0%
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?